Concepedia
Statistics
Publications
7
Citations
603
H-Index
Active since
2000
Affiliations
The Wistar Institute(Current)
DuPont (United States)
Columbia University
Lankenau Institute for Medical Research
Glenmark Pharmaceuticals (India)
Ai–xue Liu is an author at The Wistar Institute specializing in medicine, molecular biology, and cancer cell biology.
Top concepts
MedicineApoptosisCell DeathDna DamageEngineeringBiomaterialsCell BiologyPharmacologyTumor BiologyCancer Biology
Publications per year
2000–2009
RhoB Is Dispensable for Mouse Development, but It Modifies Susceptibility to Tumor Formation as Well as Cell Adhesion and Growth Factor Signaling in Transformed Cells
Ai–xue Liu, Neena S. Rane, Jeh-Ping Liu et al. · Molecular and Cellular Biology · 2001 · 207 citations · Full text
RhoB Alteration Is Necessary for Apoptotic and Antineoplastic Responses to Farnesyltransferase Inhibitors
Ai–xue Liu, Wei Du, Jeh-Ping Liu et al. · Molecular and Cellular Biology · 2000 · 157 citations · Full text
RhoB is required to mediate apoptosis in neoplastically transformed cells after DNA damage
Ai–xue Liu, George J. Cerniglia, Eric J. Bernhard et al. · Proceedings of the National Academy of Sciences · 2001 · 146 citations · Full text
Tumor Biology, Rhob Gene, Dna Damage +14
Geranylgeranylated RhoB is sufficient to mediate tissue‐specific suppression of Akt kinase activity by farnesyltransferase inhibitors
Ai–xue Liu, George C. Prendergast · FEBS Letters · 2000 · 47 citations · Full text
Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1
James B. DuHadaway, Wei Du, Scott Donover et al. · Oncogene · 2003 · 19 citations
Drug Target, Medicine, Transformation-selective Apoptotic Program +4
1–5 of 7